2014, Invention, Licensing and Public Use - Intellectual Property Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2014

Invention

Licensing

Public Use

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020. 2014; resubmitted Oct. Legislation Relating to Biologics and Biosimilars. BPCIA Litigation. Antitrust Litigation. Post-Grant Challenges at the PTAB.

Settlement

Settlement Litigation Marketing Marketing

“What’s Mine Is Not Yours To Give Me”—Nor To Take Without Just Compensation: A New Jersey’s Reaction To Sovereign Immunity, Intellectual Property, & Takings

LexBlog IP

JANUARY 5, 2022

But the Texas courts found no taking, reasoning that nothing was taken from the photographer as he still had the right to use, and license others to use, his photographs. 34,] 51-61[(2014) ]. 92, 96 (1876) (“A patent for an invention is as much property as a patent for land. at 1011, 104 S.Ct. 2d 480 (Fed.

Intellectual Property

Biosimilars 2020 Year in Review

“What’s Mine Is Not Yours To Give Me”—Nor To Take Without Just Compensation: A New Jersey’s Reaction To Sovereign Immunity, Intellectual Property, & Takings

Stay Connected